KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - Net
Ratios

Organon (OGN) R&D In Process (2021 - 2025)

Organon (OGN) has 5 years of R&D In Process data on record, last reported at $6.0 million in Q1 2025.

  • For Q1 2025, R&D In Process fell 60.0% year-over-year to $6.0 million; the TTM value through Dec 2025 reached $6.0 million, down 92.59%, while the annual FY2025 figure was $6.0 million, 92.59% down from the prior year.
  • R&D In Process reached $6.0 million in Q1 2025 per OGN's latest filing, down from $51.0 million in the prior quarter.
  • Across five years, R&D In Process topped out at $97.0 million in Q2 2022 and bottomed at $6.0 million in Q1 2025.
  • Average R&D In Process over 5 years is $34.0 million, with a median of $15.0 million recorded in 2024.
  • Peak YoY movement for R&D In Process: tumbled 60.0% in 2022, then surged 87.5% in 2024.
  • A 5-year view of R&D In Process shows it stood at $79.0 million in 2021, then tumbled by 87.34% to $10.0 million in 2022, then dropped by 20.0% to $8.0 million in 2023, then surged by 537.5% to $51.0 million in 2024, then crashed by 88.24% to $6.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for R&D In Process were $6.0 million in Q1 2025, $51.0 million in Q3 2024, and $15.0 million in Q2 2024.